Wenthur, C. J. (2023). Expedited Evaluation of Conformational Stability-Heterogeneity Associations for Crude Polyclonal Antibodies in Response to Conjugate Vaccines. Analytical Chemistry.
Wenthur, C. J. (2023). Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice. ACS Pharmacology & Translational Science.
Wenthur, C. J. (2023). In Vivo Validation of Psilacetin as a Prodrug Yielding Modestly Lower Psilocin Exposure than Psilocybin. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2023.1303365
Georgieva, J. V., Katt, M., Ye, Z., Umlauf, B. J., Wenthur, C. J., & Shusta, E. V. (2022). The 46.1 Antibody Mediates Neurotensin Uptake into the CNS and the Effects Depend on the Route of Intravenous Administration.. Pharmaceutics, 14(8). https://doi.org/10.3390/pharmaceutics14081706
Worob, A., & Wenthur, C. J. (2022). Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity.. Vaccines, 10(8). https://doi.org/10.3390/vaccines10081253
Navarro, G., Rea, W., Quiroz, C., Moreno, E., Gomez, D., Wenthur, C. J., Casadó, V., Leggio, L., Hearing, M. C., & Ferré, S. (2022). Complexes of Ghrelin GHS-R1a, GHS-R1b, and Dopamine D(1) Receptors Localized in the Ventral Tegmental Area as Main Mediators of the Dopaminergic Effects of Ghrelin.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 42(6), 940-953. https://doi.org/10.1523/JNEUROSCI.1151-21.2021
Wenthur, C. J. (2021). Pocket guide – CPIC and FDA labeling guidelines. J Pharm Soc Wis. , 24(6), 44-45.
Wenthur, C. J. (2021). Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine. . ACS Chemical Neuroscience. https://doi.org/https://doi.org/10.1021/acschemneuro.1c00498
Banks, M. I., Zahid, Z., Jones, N. T., Sultan, Z. W., & Wenthur, C. J. (2021). Catalysts for Change: The Neurobiology of Psychedelics. Molecular Biology of the Cell.
Wartenweiler, V. M., Chung, G. S., Stuart, Z., & Wenthur, C. J. (2021). Pharmacy Stakeholder Reports on Ethical and Logistical Considerations in Anti-Opioid Vaccine Development. . BMC Medical Ethics. https://doi.org/10.21203/rs.3.rs-38314/v2
Wenthur, C. J., & Gallimore, C. (2021). Chapter 12: Mental Health. In & J. Zorek (Eds.), Interprofessional Practice in Pharmacy: Featuring Illustrated Case Studies. McGraw-Hill.
Wu, S., Frey, T., & Wenthur, C. J. (2021). Naloxone acceptance by outpatient veterans: A risk-prioritized telephone outreach event. . Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2020.08.010.
Kyzer, J. L., McGuire, M., Park, H., Belz, T. F., Bonakdar, R., Janda, K. D., & Wenthur, C. J. Anti-opioid antibodies in individuals using chronic opioid therapy for lower back pain. ACS Pharmacology and Translational Science, 3(5), 896 – 906. https://doi.org/10.1021/acsptsci.0c00057
Worob, A., & Wenthur, C. J. (2019). Dark Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2). ACS Chemical Neuroscience, 11(23), 3881-3892. https://doi.org/10.1021/acschemneuro.9b00586
Wenthur, C. J. (2019). Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin.. Scientific Reports, 9(1), 1841.
Hwang, C., Smith, L., Wenthur, C. J., Ellis, B., Zhou, B., & Janda, K. (2019). Heroin Vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences. Vaccine, 37, 4155-4163.
Wenthur, C. J., Legenza, L., Weinfurter, N., Lorenzen, A., & Bowen, D. (2019). The Pharmacists Role in Combating Statewide Epidemics. JPSW.
Hwang, C. S., Bremer, P. T., Wenthur, C. J., Ho, S. O., Chiang, S., Ellis, B., Zhou, B., Fujii, G., & Janda, K. D. (2018). Enhancing efficacy and stability of an anti-heroin vaccine: Examination of antinociception, opioid binding profile, and lethality. Molecular Pharmaceutics, 15(3), 1062-1072.